4
Changes in Ownership
Kura Oncology, Inc. Filed Acc 0000950170-25-010137
SVP, Finance & Accounting sold 4,949 shares at $7.87 ($38,958)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DOYLE THOMAS JAMES SVP, Finance & Accounting | 2025-01-28 | Sale | −2,241 | $7.87 | $17,641 | 90,901 | D: show line 1 in the form |
| DOYLE THOMAS JAMES SVP, Finance & Accounting | 2025-01-28 | Sale | −887 | $7.87 | $6,982 | 90,014 | D: show line 2 in the form |
| DOYLE THOMAS JAMES SVP, Finance & Accounting | 2025-01-28 | Sale | −699 | $7.87 | $5,502 | 89,315 | D: show line 3 in the form |
| DOYLE THOMAS JAMES SVP, Finance & Accounting | 2025-01-28 | Sale | −1,122 | $7.87 | $8,832 | 88,193 | D: show line 4 in the form |
| Open-market sales · 4,949 sh · avg $7.87 · $38,958 | |||||||
Loading xslF345X05/ownership.xml…